Contact us   Site map   Create an account
 
Search
   
 

Discovery and Engineering of Antibodies

MilleGen is a  Biotech company specialised in Human Antibody Discovery and Genetic Engineering of Monoclonal Antibodies.

MilleGen’s antibody technology platform allows the generation of human monoclonal antibodies from an optimized quality library as well as affinity maturation through a powerful Directed Molecular Evolution technology (MutaGen).



Custom Services
MilleGen provides a know-how experience and expertise to research and industrial customers. The company offers an array of outsourcing options including High-Throughput DNA Sequencing, Bioinformatics, Peptides Synthesis and Antibodies Engineering & Production.


>Quick access to products & services


About MilleGen|Legal Notices




Designed by Orealys
 

Latest News    


Successful evaluation by the "Fonds Unique Interministériel" (10 AP FUI) to fund a collaborative project (MabEffect) between  LFB Biotechnologies, UMR6239 CNRS - Université François Rabelais de Tours and MilleGen SA.

Access to all news 



MilleGen  key patent of molecular evolution technology (MutaGenTM) was granted in the United States (US7670809B2).

Access to all news 


MilleGen will attend several major conferences.
Read the Events and Conferences


MilleGen scientific publications.
Access to scientific publications